Johnson & Johnson Current Ratio 2006-2018 | JNJ

Historical current ratio values for Johnson & Johnson (JNJ) over the last 10 years.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $92.695B $76.450B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $222.220B 13.67
Novartis AG (NVS) Switzerland $190.657B 16.36
Merck (MRK) United States $168.566B 15.06
AbbVie (ABBV) United States $141.089B 14.39
Novo Nordisk (NVO) Denmark $123.252B 20.42
Sanofi (SNY) France $106.218B 13.44
GlaxoSmithKline (GSK) United Kingdom $103.814B 14.19
Eli Lilly (LLY) United States $96.028B 19.07
AstraZeneca (AZN) United Kingdom $94.148B 9.86
Bristol-Myers Squibb (BMY) United States $92.695B 18.24